Kyverna Therapeutics (KYTX) Net Cash Flow Growth (1y) (2024 - 2026)

Kyverna Therapeutics (KYTX) Net Cash Flow Growth (1y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (1y) (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	198.34%
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	467.41%
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-14,223.53%
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	453.08%
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Kyverna Therapeutics	492.54 Mn	259.59 Mn	-	-131.28%

Download Data